The alveolar surface is covered by an epithelium composed of two main cell types (1, 2). Type I cells are large flat cells that cover ‫ف‬ 95% of the alveolar surface and through which gas exchange takes place, and their metabolic properties are just now being discovered (2). Type II cells have a distinct morphology with characteristic lamellar bodies, the intracellular storage form of pulmonary surfactant, and apical microvilli. Type II cells make and secrete pulmonary surfactant, and they proliferate to restore the epithelium after damage to the more sensitive type I cells. Type II cells also transport sodium and fluid from the apical to the basolateral surface and play an important role in innate immunity.
The alveolar surface is covered by an epithelium composed of two main cell types (1, 2) . Type I cells are large flat cells that cover ‫ف‬ 95% of the alveolar surface and through which gas exchange takes place, and their metabolic properties are just now being discovered (2) . Type II cells have a distinct morphology with characteristic lamellar bodies, the intracellular storage form of pulmonary surfactant, and apical microvilli. Type II cells make and secrete pulmonary surfactant, and they proliferate to restore the epithelium after damage to the more sensitive type I cells. Type II cells also transport sodium and fluid from the apical to the basolateral surface and play an important role in innate immunity.
Although methods for isolating and culturing adult rat and mouse type II cells and fetal human type II cells have been available for years, there has been limited success maintaining the differentiated functions of adult human alveolar epithelial cells in primary culture. In addition, there are no human cell lines that produce surfactant. H441 cells express surfactant protein (SP)-A and SP-B, whereas A549 cells do not express any of the surfactant proteins nor contain a higher percentage of surfactant phospholipids than fibroblasts (3) . A variety of methods for
CLINICAL RELEVANCE
This report is important to our understanding of alveolar type II cell biology and defines critical differentiation factors required for the surfactant system in adult humans.
isolating human type II cells have been published and some of their properties have been described (4) (5) (6) (7) (8) . However, maintenance of surfactant protein expression in adult human type II cells has not been established. Maintenance of differentiation of type II cells and conversion of the type II cell phenotype into a type I-like phenotype is thought to be dependent on the extracellular matrix on which the cells are cultured and on the addition of factors in the medium that promote differentiation. In fetal human type II cells, dexamethasone (Dex), isobutylmethylxanthine (IBMX), and 8-bromo-cyclic AMP (8Br-cAMP) have been shown to be important for surfactant production (9) . Markers for human type II cells include SP-A, SP-B, SP-C, and fatty acid synthase (FAS), and markers for human type I cells include receptor for advanced glycation end products (RAGE) and caveolin (10) (11) (12) . There are some reports of SP-C and RAGE expression in human alveolar epithelial cells in primary culture (5, 10, 13) . However, in general expression of SP-C decreases over the first few days of culture (8) .
The goals of this study were to determine if we could develop a system for maintaining the differentiated functions of adult human type II cells, and to determine if the phenotypes of adult human type II cells and type I-like cells are reversible in vitro.
MATERIALS AND METHODS

Alveolar Type II Cell Isolation
We modified the human type II cell isolation method published by Fang and coworkers (4) . Deidentified human lungs not suitable for transplantation and donated for medical research were obtained through the National Disease Research Interchange (Philadelphia, PA) and the International Institute for the Advancement of Medicine (Edison, NJ). The Committee for the Protection of Human Subjects at National Jewish Medical and Research Center approved this research. Briefly, the middle lobe was perfused, lavaged, and then instilled with elastase (12.9 U/ml; Roche Diagnostics, Indianapolis, IN) for 50 min at 37ЊC. The lung was minced, and the cells were isolated by filtration and partially purified by centrifugation on a discontinuous density gradient made of Optiprep (Accurate Chemical Scientific Corp., Westbury, NY) with densities of 1.080 and 1.040, and by negative selection with CD14-coated magnetic beads (Dynal Biotech ASA, Oslo, Norway) and binding to IgG-coated Petri dishes (Sigma, St. Louis, MO). The cells were counted and cytocentrifuge cell preparations were made to assess cell purity by staining for cytokeratin (CAM 5.2; DakoCytomation, Carpinteria, CA).
Culture of Human Type II and Type I-Like Cells
The freshly isolated cells were resuspended in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum SP-A  GCCATTCAGGAGGCATGTG  CGGCCGCATTGCTGTCCCA  GCCTCATTTTCCTCTGGATTCC  SP-B  TGGGAGCCGATGACCTATG  CAAGAGTGTGAGGACATCGTCCACATCC  GCCTCCTTGGCCATCTTGT  SP-C  CGGGCAAGAAGCTGCTTCT  CCACACCGCAGGGACAAACCCT  CCCCAAGCTCCCATTTCTC  FAS  GAACTCCTTGGCGGAAGAGA  CACCCGCTCGGCATGGCTATCTT  GGACCCCGTGGAATGTCA  36B4 CCACGCTGCTGAACATGCT AACATCTCCCCCTTCTCCTTTGGGCT TCGAACACCTGCTGGATGAC Definition of abbreviations: FAS, fatty acid synthase; SP, surfactant protein.
(FBS) and 2 mM glutamine, 2.5 g/ml amphotericin B, 100 g/ml streptomycin, 100 g/ml penicillin G, and 10 g/ml gentamicin (GIBCO BRL, Life Technologies Inc., Rockville, MD). For the Matrigel system (basolateral access), 5 ϫ 10 6 cells were plated on Matrigel (BD Biosciences, Bedford, MA) in a 35-mm well. After adherence for 24-48 h, the medium was switched to 1% charcoal-stripped FBS (CS-FBS), 10 ng/ml keratinocyte growth factor (KGF, K; R&D Systems, Minneapolis, MN), 0.1 mM isobutylmethylxanthine (IBMX, I), and 0.1 mM 8Br-cAMP (A). Dex (D, 10 nM; Sigma) was added 2 d later along with the other additives and every other day thereafter. For the apical access system, 2.5 million cells were plated on 4.2 cm 2 millicell inserts (Millipore Corp., Bedford, MA) that had been previously coated with a mixture of 60-65% Matrigel and 40-35% rat-tail collagen in DMEM with 10% FBS (14) . After 24-48 h the media was changed to 5% FBS plus KIA additives or 1% CS-FBS plus KIA additives. Dex was added to the KIA additives 2 d later and KIAD was added every other day thereafter. To transdifferentiate type II cells to type I-like cells, type II cells were plated on rat tail collagen-coated dishes at a density of 0.5-1.0 ϫ 10 5 /cm 2 in DMEM with 10% FBS (15) . After 24-48 h the medium was changed to 5% FBS without additives.
Morphology
Cells were visualized by phase microscopy, electron microscopy, and immunofluorescence as described previously (16) . Samples were prepared for electron microscopy with standard techniques (17) . For immunofluorescence the cells were fixed in paraformaldehyde or acid alcohol and then filters were embedded in paraffin as described (18) . In addition, some filter inserts were fixed in paraformaldehyde or ice-cold methanol and stained directly. The primary antibodies included mouse anti-human SP-A (PE-10), a gift from Yoshio Kuroki, Sapporo, Japan; rabbit anti-SP-B, rabbit anti-proSP-C, and mouse anti-Ep-CAM (Chemicon International, Temecula, CA); mouse anti-vimentin (V9; Santa Cruz Biotechnology, Santa Cruz, CA); goat anti-caveolin, mouse anti-CD45, mouse anti-cytokeratin (CAM5.2), and mouse anti-CD-31 (BD Biosciences, San Jose, CA); mouse anti-CD68 (DakoCytomation); rabbit anti-proSP-C (Fitzgerald Industries International, Concord, MA); goat anti-RAGE (R&D Systems); and rabbit anti-FAS, a gift of Stuart Smith (Oakland Children's Medical Center, Oakland, CA). The secondary antibodies included donkey anti-mouse IgG (Alexa 594); donkey antirabbit IgG (Alexa 488), and donkey anti-goat IgG (Alexa 594) from Molecular Probes (Eugene, OR).
Immunoblotting and Real-Time RT-PCR
Expression of protein and mRNA of corresponding genes were measured by Western blotting and real-time RT-PCR according to protocols as described previously (14) . Polyacrylamide gradient gels (8-16%; Invitrogen Corporation, Carlsbad, CA) run in tris glycine buffer were used to separate proteins. Proteins were run in the reduced state except for SP-B, which was run unreduced. For Western blotting, protein loading was normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or actin. For real-time RT-PCR, the expression levels of genes were expressed as a ratio to the expression of the constitutive probe 36B4, acidic ribosomal phosphoprotein P0 (19) . The specific primers and probes used in these experiments are listed in Table 1 .
Lipid Synthesis
Lipid synthesis by type II cells cultured on the apical system was performed as described previously (14) . Briefly, on Day 7 of culture (after 6 d with additives), the cells were incubated with 5 Ci/ml [1-
acetate (specific activity 25-60 Ci/mmol; MP Biomedicals, Irvine, CA) for 4 h. Lipids were extracted with methanol and chloroform and separated by two-dimensional thin-layer chromatography on silica gel 60-well plates, as described previously (14) . The first solvent system was chloroform:methanol:acetic acid (130:50:20, vol/vol/vol) and the second solvent system was chloroform:methanol:formic acid (130:50:20, vol/ vol/vol). The plates were exposed to iodine vapor, individual lipids spots were scraped into vials for scintillation counting, and their incorporated radioactivity was determined. Separate inserts were used to measure DNA as described previously (14) .
Statistic Analysis
Data from gene expression was processed through a nonparametric, paired t test and lipid data were analyzed by paired t tests.
RESULTS
Cell Isolation
In general we used the right middle lobe so that most of the lobe was surrounded by pleura and leaked minimally during lavage or instillation of elastase. After the negative selection by panning on IgG-coated Petri dishes, the yield was 344 Ϯ 40 ϫ 10 6 cells (mean Ϯ SE, n ϭ 16), and the cell purity was 82 Ϯ 0.5%. The purity was further increased by adherence to the matrix in culture. The purity of the epithelial monolayers on EHS or the apical access system was Ͼ 90% as determined by immunostaining for SP-A, cytokeratin, or Ep-CAM and Ͻ 10% for other cells as determined by staining for vimentin, CD-45, CD-31, and CD-68.
Matrigel Basolateral Access System
The type II cells formed spherules when they were cultured on Matrigel, as well described for rat type II cells (20) (Figure 1A) . By immunostaining nearly all the cells expressed SP-A and proSP-C ( Figures 1B and 1C) . Some of the SP-A was in the lumen of the spherules. There were only rare cells that stained for CD-68, a macrophage marker (data not shown). An electron micrograph through one of these aggregates is shown in Figure 1D . Most of the apical surface, as indicated by microvilli, faced the internal lumen. Cells cultured on Matrigel had abundant lamellar inclusions, well formed intracellular organelles, and were joined by tight junctions. The mRNA levels for differentiation markers normalized to the expression of a constitutive probe varied from experiment to experiment. However, as shown in Figure 2A , there was a consistent increase in the mRNA levels for SP-A, SP-B, SP-C, and FAS relative to the constituent probe 36B4 upon the addition of KIAD. Because of the variability from experiment to experiment and the relatively high level of expression of SP-A without any addition, detailed evaluation of the individual additives at the mRNA level was not done. Protein expression in the Matrigel system was measured by immunoblotting ( Figure 2B ). FAS showed the highest level of expression with the combination of KIAD. There was a similar increase in proSP-C with KIAD, but there was little effect of the additives on the level of SP-A and SP-B in these experiments.
Apical Access System
One of the difficulties with the Matrigel system is that the cells form aggregates, and most of the apical surface faces inward toward the lumen (20) . Surfactant accumulates in the lumen of these aggregates, and therefore the immunoblotting for SP-A represents both intracellular and extracellular secreted SP-A. To provide access to the apical surface, we developed a system in which most of the cells form a monolayer (14) (15) (16) 21) . With rat type II cells, KGF causes obvious proliferation, and the cells form a complete monolayer in the presence of rat serum. However, KGF does not have as dramatic proliferative response with human type II cells. To prevent cell spreading, the percentage of Matrigel was increased. The cells form islands or aggregates on this matrix ( Figure 3A) . However, there were also some spherules seen in individual wells. By immunocytochemistry, most cells expressed SP-A and proSP-C ( Figures 3B and 3C ). These cells also expressed SP-B, cytokeratin, Ep-CAM, and low levels of SP-D; these cells were negative for vimentin, CD-68, 
CD-
in these cultures. The amount of contaminating cells varied with the different isolations. By electron microscopy, the alveolar epithelial cells have apical microvilli, and the lamellar bodies appear to be distributed preferentially toward the apical surface ( Figure 3D ). The cells were cultured with 5% FBS or 1% CS-FBS, and the results were quite similar. As shown in Figure 4A , the mRNA levels for SP-A, SP-B, SP-C, and FAS all increased with the addition of KIAD in the presence of 5% FBS or 1% CS-FBS. At the protein level, the addition of the combination of the KIAD increased expression of FAS, SP-A, SP-B, and proSP-C in the presence of 5% FBS or 1% CS-FBS ( Figure 4B ). The expression of SP-D was significantly less than that of SP-A, and was excluded from our analyses.
Additional studies were done to evaluate the effects of individual additives and time in culture at the protein level in the apical access system. The combination of all the additives increased the expression of FAS ( Figure 5 ). SP-A was increased by KGF and was highly expressed under all conditions. SP-B and proSP-C were stimulated by Dex. However, proSP-C was inhibited by the combination of IBMX and 8Br-cAMP. As seen in the time course, freshly isolated cells expressed surfactant proteins at the beginning of culture, lost expression over the next few days, and then regained their expression after 4-6 d in the presence of KIAD ( Figure 6A ). Compared with type II cells, there was no detectable expression of SP-A, SP-B, or proSP-C after 7 d of culture on rat-tail collagen-coated wells ( Figure 6A ). In these studies, we saw no effect of removing the medium from the apical surface to provide an air-liquid interface at the surface of the monolayer, which is known to be important for ciliated cells of the bronchial epithelium ( Figure 6A ).
Since type II cells are the major lipogenic cell type in the lung, differentiation of these cells should include increased lipogenesis. KIAD significantly increased FAS mRNA and protein levels ( Figures 4A and 4B) . We also measured acetate incorporation as an indicator of lipogenesis. As shown in Table 2 , there was an increase in the rate of acetate incorporation due to KIAD in the presence of 1% CS-FBS, which was predominantly due to an increase in phospholipids as contrasted to neutral lipids. However, there was not much change in the types of phospholipids synthesized. Individual species of phosphatidylcholine were not determined in these experiments. The rate of acetate incorporation into phosphatidylcholine was increased by KIAD 5.47-Ϯ 0.03-fold in 1% CS-FBS and 3.33-Ϯ 0.73-fold in 5% FBS (n ϭ 4).
Type I-Like Cells
Type II cells plated on tissue culture plastic or collagen-coated wells characteristically spread and flatten, lose their ability to express type II cell markers, and express some type I cell markers (15, 21, 22) . The adult human type II cells cultured on plastic or collagen-coated coverslips or wells behaved similarly. As shown in Figure 6B , the level of SP-A decreases rapidly, whereas the type I cell markers, receptor for advanced glycation endproducts (RAGE) and caveolin 1, appear over a few days. These type I-like cells are large and flat, but they still contain some residual lamellar bodies (data not shown).
Reversibility of the Phenotype
The type II cell phenotype is thought to be dependent on the culture conditions and to be reversible in part (23, 24) . Rat type II cells cultured on Matrigel express markers of the type II cell phenotype, whereas type II cells cultured on tissue culture plastic or rat tail collagen lose markers of the type II phenotype and express markers of the type I cell phenotype (15) . As shown in (Figure 7 ). These data indicate that the phenotype of these cells is determined by the in vitro conditions and is, in part, reversible.
DISCUSSION
To study the diverse functions of adult human alveolar type II cells, which include surfactant production, alveolar repair, fluid transport, and innate immunity, it would be useful to have a highly differentiated primary culture system. As stated previously, cell lines of differentiated type II cells are not available. Reported culture systems for adult human type II cells have shown some expression of SP-A or SP-C, but complete characterization of these cultures is not available, and expression of surfactant proteins was not maintained in culture (5, 8, 13) . In addition, it would be useful to have epithelial cells that express some type I-like characteristics for comparative studies. However, it is highly likely that these type I-like cells, derived from isolated type II cells, are different from type I cells in vivo or freshly isolated type I cells (11) . In this study we were able to show that type II cells could re-express the surfactant proteins after the initial loss in the first few days of culture, that KGF stimulated differentiation as it does with rat type II cells, and that the phenotype was greatly dependent upon the culture microenvironment.
In the present study, we modified other published methods to isolate and culture human type II cells. We used both the apical access and Matrigel systems to maintain differentiation as we have done previously with rat type II cells (14, 25) . We developed culture conditions sufficient to induce and maintain differentiation of adult human alveolar type II cells. Cells cultured in both systems displayed distinct characteristics of type II cells in vivo such as cuboidal shape, lamellar inclusions, microvilli, and tight junctions and expression of surfactant proteins (1). However, our studies indicate that individual functions or expression of specific proteins in type II cells will likely vary with specific culture conditions. For example, cAMP and IBMX inhibited the expression of proSP-C in our system. However, human fetal type II cells respond differently. Gonzales and colleagues reported that cAMP ϩ IBMX increased SP-C in fetal type II cells (9) . In general, for fetal human type II cells, the combination of Dex, IBMX, and cAMP produced a synergistic effect on type II cell differentiation (9) With rat type II cells cultured on Matrigel, Shannon and colleagues showed that forskolin or IBMX plus forskolin reduced the expression of SP-A but not SP-C in the presence of KGF (26) . Hence, the response of human adult alveolar type II cells to different additives in culture is different from fetal human type II cells or adult rat type II cells. Since the basic interest in our laboratory is lipogenesis, the combination of KGF, Dex, 8Br-cAMP, and IBMX appears to produce the maximal expression of FAS. As such, we feel that it is unlikely that one set of additives will maximize all human type II cell functions and that, instead, the functional characteristics of type II cells will greatly depend upon specific culture conditions and microenvironment, which includes the extracellular matrix. Specific culture conditions should probably be tailored to the specific function being investigated.
It is likely that we and other researchers will improve upon this culture system. The current series of experiments evaluated only a limited number of soluble additives or growth factors. It is probable that other additives or growth factors such as transforming growth factor-␣ or hepatocyte growth factor will be important. In our experiments there was a marked variation in level of mRNA for the differentiation markers SP-A, SP-B, SP-C, and FAS from isolation to isolation. The reasons for these variations are not clear at this time. Unfortunately, there are numerous potential sources for this variation, and these include the age, sex, administered medicines, and smoking history of the donor; the cause of death; the techniques used to harvest the lung; the transport media; the time of transport; the actual isolation procedure; the culture reagents; use of fresh versus frozen cells; and so on. These variables will have to be evaluated in future experiments.
There have been reports that the phenotype of the type II cells is reversible in vitro (23, 24) . Our studies support the concept of the plasticity of the phenotype and modulation of the phenotype in vitro by the culture microenvironment. Type II cells cultured Definition of abbreviations: CS-FBS, charcoal-stripped FBS; FBS, fetal bovine serum; KIAD, keratinocyte growth factor ϩ 3-isobutyl-1-methylxanthine ϩ cyclic AMP ϩ dexamethasone; LysoPC, lysophosphatidylcholine; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PG, phosphatidylglycerol; PI, phosphatidylinositol; PS, phosphatidylserine; SM, sphingomyelin.
Type II cells were cultured in the apical access system with the specified media for 6 d. Incorporation of (1-14 C) acetate was measured over the last 4 h. The data are expressed at cpm/g DNA or as percent incorporation into total lipids or individual phospholipids. The results represent the mean Ϯ SE for four independent experiments. The phospholipids measured were LysoPC, SM, PC, PS, PI, PE, and PG.
* Indicates there is significant difference between with and without KIAD (P Ͻ 0.05). These studies and the studies of others indicate that type II cells can be isolated from adult human lung and that their differentiated functions can be maintained in primary culture. However, the actual phenotype of these cells is dependent upon the culture microenvironment that includes the extracellular matrix on which the cells are grown. These cells should be useful to define the regulation of specific type II cell functions, their role in innate immunity, and their interactions with other cells in the alveolar compartment.
